What Researchers Did
Researchers reviewed the applicability of animal tumour data to human cancer therapy, focusing on tumour hypoxia, dose fractionation, and chemo-radiotherapy.
What They Found
The review highlighted that applying animal tumour data to human cancer therapy is complex, with many instances of premature application or inadequate consideration of animal observations in clinical study design. It explored how animal models have informed clinical trials in three key areas: tumour hypoxia, dose fractionation, and chemo-radiotherapy, emphasizing their utility beyond just screening new agents.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
As a review from 1988, this study's insights into the applicability of animal tumour data may not fully reflect current advancements in cancer research and clinical trial methodologies.